These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5496789)

  • 41. Intensive short course chemotherapy in the management of tuberculous meningitis.
    Donald PR; Schoeman JF; Van Zyl LE; De Villiers JN; Pretorius M; Springer P
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):704-11. PubMed ID: 9755923
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Biweekly treatment of pulmonary tuberculosis by isoniazid and streptomycin with or without initial continuous phase. Results obtained in Algeria].
    Larbaoui D; Abderrahim K
    Rev Tuberc Pneumol (Paris); 1968 Nov; 32(7):939-48. PubMed ID: 5729100
    [No Abstract]   [Full Text] [Related]  

  • 43. Intermittent chemotherapy for tuberculosis. A statement by the committee on therapy.
    Simpson DG; Brummer DL; Chaves AD; Cugell DW; Dickie HA; Hepper NG; Pierce AK; Ziskind MM
    Am Rev Respir Dis; 1969 Aug; 100(2):257-9. PubMed ID: 5805274
    [No Abstract]   [Full Text] [Related]  

  • 44. [Sterilizing activity of the main drugs on the mouse experimental tuberculosis (author's transl)].
    Grosset J; Truffot C; Fermanian J; Lecoeur H
    Pathol Biol (Paris); 1982 Jun; 30(6):444-8. PubMed ID: 6810288
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Side effects of ETA combined with INH and SM in the first antituberculous treatment of pulmonary tuberculosis].
    Sosnowski W; Rozniecki J; Kubiak Z; Pruszyńska S
    Gruzlica; 1968 Oct; 36(10):983-5. PubMed ID: 5710105
    [No Abstract]   [Full Text] [Related]  

  • 46. [Treatment of 100 pulmonary tubercular patients whose bacilli are resistant to streptomycin, isoniazid and ethionamid, with a combination of rifampicin and ethambutol. Comparison between 2 dosages of rifampicin (weekly treatment for 4 months, biweekly for 8 months after)].
    Hétrick G; Muñoz I; Ras R
    Rev Tuberc Pneumol (Paris); 1970; 34(5):715-6. PubMed ID: 5496795
    [No Abstract]   [Full Text] [Related]  

  • 47. [Comparative study of 2 types of oral therapy of pulmonary tuberculosis (ethionamide and isoniazid, thiacetazone and isoniazid)].
    Chicou FJ; Hétrick G; Huet M; Radenac H; Rist N
    Bull World Health Organ; 1968; 39(5):731-69. PubMed ID: 4183287
    [No Abstract]   [Full Text] [Related]  

  • 48. [Tuberculosis among hemodialysis patients in Dakar, apropos of 2 cases].
    Diouf B; Niang A; Pouye A; Diouf ML; Mbengue M; Ka MM; Moreira-Diop T; Bao O
    Dakar Med; 1998; 43(1):129-31. PubMed ID: 9874594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Agranulocytosis due to anti-tuberculosis drugs including isoniazid (INH) and rifampicin (RFP)--a report of four cases and review of the literature].
    Shishido Y; Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Komatsu H; Yotsumoto H
    Kekkaku; 2003 Nov; 78(11):683-9. PubMed ID: 14672045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surveillance of Mycobacterium tuberculosis drug resistance in Hong Kong, 1986-1999, after the implementation of directly observed treatment.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2001 Sep; 5(9):815-23. PubMed ID: 11573892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experiments on long-term intermittent chemotherapy in advanced tuberculosis in mice.
    Canetti G; Grumbach F
    Tubercle; 1968 Mar; 49():Suppl:70-4. PubMed ID: 4968931
    [No Abstract]   [Full Text] [Related]  

  • 52. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Intermittent chemotherapy in murine tuberculosis.
    Batten JC
    Tubercle; 1968 Mar; 49():Suppl:70. PubMed ID: 5659246
    [No Abstract]   [Full Text] [Related]  

  • 54. Pharmacokinetics of antituberculosis drugs after oral isolated and simultaneous administration in triple combination.
    Zítková L; Janků I; Tousek J; Papezová E; Stastná J
    Czech Med; 1983; 6(4):202-17. PubMed ID: 6420125
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Classical chemotherapy: the intermittent method in freshly diagnosed pulmonary tuberculosis. Preliminary report].
    Zierski M
    Gruzlica; 1970; 38(7):731-2. PubMed ID: 5453684
    [No Abstract]   [Full Text] [Related]  

  • 56. [Direct evaluation of the results of treatment of cutaneous tuberculosis with streptomycin, isoniazid and ethambutol].
    Arkuszewska C
    Przegl Dermatol; 1980; 67(1):97-101. PubMed ID: 7375659
    [No Abstract]   [Full Text] [Related]  

  • 57. [Desensitization therapy for allergic reactions of antituberculous drugs--evaluation of desensitization therapy according to the guideline of the Japanese Society for Tuberculosis].
    Kobashi Y; Okimoto N; Matsushima T; Abe T; Nishimura K; Shishido S; Kawahara S; Shigeto E; Takeyama H; Kuraoka T
    Kekkaku; 2000 Dec; 75(12):699-704. PubMed ID: 11201137
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effectiveness of antibacterial preparations incorporated into liposomes in the treatment of experimental tuberculosis].
    Kurunov IuN; Nikolin VP; Kaledin VI; Matienko NA; Budker VG
    Probl Tuberk; 1982 Oct; (10):54-8. PubMed ID: 7178105
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis].
    Brant AL; Semenova EA
    Antibiotiki; 1981 Aug; 26(8):628-32. PubMed ID: 7294755
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Effectiveness of the rapid intravenous administration of rifampicin and isoniazid and of the intramuscular administration of streptomycin in disseminated destructive pulmonary tuberculosis in dogs].
    Bondarev IM; Ivanov VL; Novoselova VP; Kovaleva LA; Shtegel'man LA
    Antibiotiki; 1984 Jun; 29(6):430-4. PubMed ID: 6476805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.